for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Aspen Pharmacare Holdings Limited

APNJ.J

Latest Trade

14,642.00ZAc

Change

83.00(+0.57%)

Volume

1,116,881

Today's Range

14,370.00

 - 

14,743.00

52 Week Range

8,000.00

 - 

16,514.00

As of on the Johannesburg Stock Exchange ∙ Minimum 15 minute delay

Pricing

Previous Close
14,559.00
Open
14,743.00
Volume
1,116,881
3M AVG Volume
25.98
Today's High
14,743.00
Today's Low
14,370.00
52 Week High
16,514.00
52 Week Low
8,000.00
Shares Out (MIL)
455.52
Market Cap (MIL)
66,454.78
Forward P/E
10.80
Dividend (Yield %)
--

Next Event

Half Year 2021 Aspen Pharmacare Holdings Ltd Earnings Release

Latest Developments

More

Aspen Announces Deal With J&J To Make COVID-19 Vaccine

Aspen Pharmacare Updates On Divestment Of European Thrombosis Business To Mylan

Aspen Pharmacare Posts FY Normalised HEPS From Cont Ops Of 1464,6 CENTS

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Aspen Pharmacare Holdings Limited

Aspen Pharmacare Holdings Limited is a South Africa-based supplier and manufacturer of branded and generic pharmaceutical products, as well as infant nutritional and consumer healthcare products. The Company's segments include International, South Africa, Asia Pacific and Sub-Saharan Africa (SSA). Its International business includes operating subsidiaries in Europe, Commonwealth of Independent States (CIS), Latin America, the Middle East and North Africa, Canada, as well as Mauritius-based Aspen Global Incorporated. The South African business provides branded, generic, over-the-counter, consumer health and infant nutritional products, which are supplied to pharmacies, retail pharmacy chains, hospitals, clinics, prescribing specialists, dispensing general practitioners, managed healthcare funders and retail stores across the private and public sectors in South Africa. Its business in Asia Pacific includes operations in Australasia, the Philippines, Taiwan and Japan.

Industry

Biotechnology & Drugs

Contact Info

Woodmead

2194

South Africa

+27.31.5808600

http://www.aspenpharma.com/

Executive Leadership

Kuseni Douglas Dlamini

Independent Non-Executive Chairman of the Board

Stephen Bradley Saad

Group Chief Executive, Executive Director

Michael Guy Attridge

Deputy Group Chief Executive Officer, Finance Director, Executive Director

Sean Capazorio

Group Finance Officer

Samer Kassem

Chief Executive Officer, Aspen Global Inc

Key Stats

2.50 mean rating - 6 analysts
Sell
Hold
Buy
Revenue (MM, ZAR)

2018

42.6K

2019

38.9K

2020

38.6K

2021(E)

41.0K
EPS (ZAR)

2018

16.050

2019

14.143

2020

12.680

2021(E)

13.254
Price To Earnings (TTM)
14.41
Price To Sales (TTM)
1.72
Price To Book (MRQ)
0.96
Price To Cash Flow (TTM)
10.70
Total Debt To Equity (MRQ)
61.14
LT Debt To Equity (MRQ)
52.04
Return on Investment (TTM)
4.24
Return on Equity (TTM)
3.61

Latest News

Latest News

South Africa's Aspen agrees initial deal to make J&J vaccine candidate

South African pharmaceutical company Aspen Pharmacare <APNJ.J> said on Monday it had reached a preliminary agreement with Johnson & Johnson <JNJ.N> to commercially manufacture its COVID-19 vaccine candidate, sending its shares higher.

South Africa's Aspen to seek acquisitions in emerging markets

South African pharmaceutical major Aspen Pharmacare Holdings Ltd said on Thursday it is planning to expand its portfolio in emerging markets through a mix of organic growth and acquisitions, as part of a new strategy.

UPDATE 1-S.Africa's Aspen sells thrombosis drug business to Mylan, shares jump

South African drugmaker Aspen Pharmacare has agreed to sell the rights to its European thrombosis business to U.S. pharmaceutical company Mylan for almost 642 million euros ($759 million), sending its shares up 7% on Tuesday.

Aspen offers to cut cancer drug prices, may avoid EU antitrust fine

Aspen <APNJ.J> has offered to cut prices by an average of 73% for six off-patent cancer drugs, EU antitrust regulators said on Tuesday, a move that could help the South African pharmaceutical company avoid a potentially hefty fine.

BRIEF-UK's CMA Says Aspen, Tiofarma, Amilco Admit Taking Part In Anti-Competitive Agreement

* CMA LEVIES FINES OF £2.3M AND SECURES £8M FOR NHS IN PHARMA PROBE

BRIEF-Aspen Pharmacare Says UK Competition Regulator Confirms Fine Of About 2.1 Mln Stg On Co

* JSE: APN - COMPLETION OF UNITED KINGDOM COMPETITION AUTHORITY INVESTIGATION

South Africa's Aspen could supply 10 million dexamethasone pills in COVID-19 crisis

South African pharmaceutical major Aspen could provide 10 million dexamethasone tablets within a month, Chief Executive Stephen Saad said on Tuesday after the World Health Organisation cautioned about the drug's supply.

Aspen could produce 10 mln dexamethasone tablets within a month -CEO

South African pharmaceutical maker Aspen could provide 10 million dexamethasone tablets within a month, CEO Stephen Saad told Reuters on Tuesday.

S.Africa's Aspen says it has capacity to meet demand for dexamethasone

South Africa's pharmaceutical giant Aspen Pharmacare Holdings Ltd said on Monday the company had sufficient local capacity to produce injections to meet any demand surge for dexamethasone.

BRIEF-Aspen Pharmacare Says It Owns Rights To Dexamethasone

* USE OF DEXAMETHASONE IN THE CLINICAL MANAGEMENT OF PATIENTS WITH COVID-19 REQUIRING RESPIRATORY INTERVENTION

UPDATE 1-South Africa's Aspen says comfortable with liquidity position; backs profit view

South Africa's Aspen Pharmacare Holdings Limited on Friday maintained its profit forecast for the year and said it was comfortable with its liquidity position amid uncertainties stemming from the novel coronavirus outbreak.

South Africa's Aspen Pharmacare maintains FY profit forecast

Aspen Pharmacare Holdings Limited on Friday maintained its profit forecast for the year and said it was comfortable with its liquidity position, amid uncertainties stemming from the novel coronavirus outbreak.

BRIEF-Aspen Pharmacare Says Review & Restructuring Of Europe CIS Business Ongoing

* STRATEGIC REVIEW AND INTERNAL RESTRUCTURING UNDERTAKEN IN RESPECT OF EUROPE CIS BUSINESS HAS BEEN ONGOING

S.African drugmaker Aspen sees no immediate impact of India's decision to curb drug exports

The deputy chief executive of South Africa's Aspen Pharmacare said on Friday the drugmaker sees no immediate impact of India's decision this week to restrict the export of 26 pharmaceutical ingredients due to the coronavirus outbreak.

South African drugmaker Aspen expects coronavirus impact

South African drugmaker Aspen Pharmacare Holdings Ltd <APNJ.J> reported a small rise in earnings in the first half of the 2020 financial year on Thursday and said the coronavirus outbreak would impact its performance.

South Africa's Aspen's half year earnings up, expects coronavirus impact

South Africa's Aspen Pharmacare Holdings Ltd reported a marginal rise in half-year normalised earnings on Thursday as the drugmaker's manufacturing unit benefited from the restart of heparin sales to third party customers.

BRIEF-Aspen Says COVID-19 Outbreak Will Inevitably Impact Performance

* JSE: APN - UNAUDITED GROUP FINANCIAL RESULTS FOR THE SIX MONTHS ENDED 31 DECEMBER 2019

Aspen forecasts H1 results ahead of estimate on restart of heparin sale

South Africa's Aspen Pharmacare Holdings Ltd said on Friday it expects to report half-year results slightly above its forecast as the drugmaker's manufacturing unit benefited from the restart of heparin sales to third party customers.

BRIEF-Aspen Pharmacare Says Half Year Results Slightly Ahead Of Guidance

* ASPEN PHARMACARE HOLDINGS LTD - RESULTS OF GROUP FOR SIX MONTHS ENDED 31 DECEMBER 2019 ARE SLIGHTLY AHEAD OF GUIDANCE

Novartis buys Aspen's Japanese generic unit for up to 400 million euros

Novartis <NOVN.S> is buying the Japanese generics unit of South Africa's Aspen Pharmacare <APNJ.J> in a deal worth up to 400 million euros ($440.80 million) to expand in the world's third-biggest drug market, the Swiss drugmaker said on Monday.

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up